Under the motto “22plusFuture,” the National Center for Tumor Diseases (NCT) Heidelberg celebrated...

Rare cancers account for 20 to 25 percent of all new cancer diagnoses worldwide, yet patients with...

On April 24, the Investigator-Initiated Trials (IIT) Forum of the NCT Heidelberg brought together...

The Clinical Translational Research Fellowship at NCT Heidelberg is designed for junior clinicians...

At the National Center for Tumor Diseases (NCT) in Heidelberg, Peter Lichter was honored on the...

Antonia Schubert, head of the early-career research group “Extracellular Vesicles and Molecular...

At the NCT, patients and their families can help shape research projects from an early stage. A new...

The Cancer Core Europe (CCE) Annual Meeting brought together researchers, clinicians, patient...

On July 22 and 23, 2026, the first conference of the newly founded International Society of Exercise...

Engaging presentations, in-depth discussions, and a large turnout—approximately 470 patients, family...